Candesartancilexetil

CAS: 145040-37-5

Ref. IN-DA00HXCN

Produktinformation

• Name: Candesartancilexetil
• Synonyme: [u"1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate", u'Amias', u'Atacand', u'Blopress', u'candesartan cilexetil', u'Kenzen', u'Parapres', u'TCV 116', u'TCV-116', u'Candesartan cilexetil', u'145040-37-5', u'Atacand', u'TCV-116', u'Amias', u'Parapres', u'Kenzen', u'TCV 116', u'Candesartan (Cilexetil)', u'CANDESARTAN CILEXTIL', u'Candesartan cilexetil [USAN]', u'CHEMBL1014', u'CHEBI:3348', u'TCY 116', u'C33H34N6O6', u'MFCD00871371', u'AK-75900', u"1H-Benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)-, hydroxide, inner salt, (+-)-", u"2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester", u'(+-)-1-Hydroxyethyl 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)', u"1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate", u'1-(cyclohexoxycarbonyloxy)ethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate', u"1-(cyclohexyloxycarbonyloxy)ethyl 1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate", u"1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-benzimidazole-7-carboxylate", u"1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate", u'1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate', u"1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester, (+-)-", u"2-ETHOXY-1-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-1H-BENZIMIDAZOLE-7-CARBOXYLIC ACID 1-[[(CYCLOHEXYLOXY)CARBONYL]OXY]ETHYL ESTER", u'Racanda', u'Candesartan hexetil', u'1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate', u'candesartan cilexitil', u'Spectrum_001707', u'AC1L1DWQ', u'DSSTox_CID_239', u'Spectrum2_000485', u'Spectrum3_000996', u'Spectrum4_001124', u'Spectrum5_001462', u'DSSTox_RID_85567', u'Candesartan-cilexetil-Atacand', u'DSSTox_GSID_20239', u'SCHEMBL40831', u'BSPBio_002691', u'KBioGR_001607', u'KBioSS_002187', u'MLS004774127', u'Candesartan cilexetil , 97%', u'SPECTRUM1504261', u'SPBio_000349', u'GTPL8352', u'Candesartan cilexetil (Atacand)', u'DTXSID5020239', u'KBio2_002187', u'KBio2_004755', u'KBio2_007323', u'KBio3_001911', u'KS-00000IVU', u'EBD4212', u'GHOSNRCGJFBJIB-UHFFFAOYSA-N', u'HMS1922J09', u'HMS2093E20', u'HMS3651I08', u'Pharmakon1600-01504261', u'BCP22050', u'Candesartan cilexetil (JP17/USAN)', u'Tox21_302202', u'AC-204', u'BDBM50318907', u'BG0573', u'CCG-39530', u'NSC758697', u's2037', u'STL451065', u'AKOS015894954', u'AKOS015920180', u'AB07617', u'AM90293'], (±)-1-Hydroxyethyl 2-ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)l]-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester), 1-Cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate, 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-([4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl)-1H-1,3-benzodiazole-7-carboxylate, 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate, 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester, 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester, 2-Ethoxy-1-[(2′-(1H-tetrazol-5-yl)-1,1′-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester, Atacand, Blopress, Tcv 116, Tcy 116
• Marke: Indagoo

Chemische Eigenschaften

• Molekulargewicht: 610.6597
• Formel: C₃₃H₃₄N₆O₆
• Reinheit: 98%
• Farbe/Form: Solid
• InChl: InChI=1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)
• InChI Key: GHOSNRCGJFBJIB-UHFFFAOYSA-N